ClearPoint Neuro Inc [CLPT] stock is trading at $16.68, up 13.78%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CLPT shares have gain 39.00% over the last week, with a monthly amount glided 43.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on October 24, 2023, and set its price target to $8. Lake Street initiated its recommendation with a Buy and recommended $32 as its price target on March 18, 2021. B. Riley FBR started tracking with a Buy rating for this stock on July 17, 2020, and assigned it a price target of $8.
ClearPoint Neuro Inc [CLPT] stock has fluctuated between $5.11 and $14.78 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. ClearPoint Neuro Inc [NASDAQ: CLPT] shares were valued at $16.68 at the most recent close of the market. An investor can expect a potential drop of -10.07% based on the average CLPT price forecast.
Analyzing the CLPT fundamentals
ClearPoint Neuro Inc [NASDAQ:CLPT] reported sales of 30.43M for the trailing twelve months, which represents a growth of 40.96%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -0.62%, Pretax Profit Margin comes in at -0.6%, and Net Profit Margin reading is -0.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -0.62 and Total Capital is -0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.12 points at the first support level, and at 13.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.85, and for the 2nd resistance point, it is at 19.03.
Ratios To Look Out For
For context, ClearPoint Neuro Inc’s Current Ratio is 4.54. Also, the Quick Ratio is 3.61, while the Cash Ratio stands at 2.86. Considering the valuation of this stock, the price to sales ratio is 15.12, the price to book ratio is 15.87.
